Personalized Digital Remote Monitoring for Elderly Patients

NCT ID: NCT06845917

Last Updated: 2025-02-25

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Clinical Phase

NA

Total Enrollment

700 participants

Study Classification

INTERVENTIONAL

Study Start Date

2025-06-15

Study Completion Date

2027-10-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Objective This clinical investigation aims to evaluate whether the EPOCA Remote Monitoring System (RMS) enhances care for elderly patients with multiple chronic conditions and reduces unplanned hospitalizations.

Key Research Questions

This study will assess:

* Unplanned Hospitalizations: Does EPOCA RMS reduce the total number of unplanned hospital days over 12 months?
* Quality of Life \& Costs: What is the impact of EPOCA RMS on patients' quality of life and overall healthcare costs?
* Survival Rates: Does EPOCA RMS improve survival rates compared to standard care?

Participant Criteria

Participants must:

* Be 75 years or older with at least three chronic conditions.
* Have experienced a hospitalization or fall in the past year.
* Be randomly assigned to either the EPOCA RMS group or a control group receiving standard care.
* Be monitored for 12 months, with data collected at multiple time points.

Study Design

* Type: Multicenter, randomized controlled trial (RCT).
* Sites: Conducted across 8 hospitals in France.
* Duration: 12-month follow-up.
* Sample Size: 700 participants (350 per group).
* Intervention Group: Remote monitoring through the EPOCA RMS, integrating connected devices and medical coordination.
* Control Group: Standard care follow-up.

Expected Outcomes

* Reduced unplanned hospital stays and emergency visits.
* Improved quality of life and patient satisfaction.
* Comprehensive cost-effectiveness analysis and economic impact assessment.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Elderly Patients Polypathology Multiple Chronic Conditions

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Multicentric Randomized controlled trial with two arms (intervention vs. control) for remote monitoring system
Primary Study Purpose

OTHER

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Control arm: standard follow-up

Patients in the control group will receive standard medical care from their general practitioner or their geriatrician. In addition to the standard follow-up, they will be contacted for data collection purposes.

Group Type NO_INTERVENTION

No interventions assigned to this group

Intervention arm: Patients followed by a Remote Monitoring System

Group Type EXPERIMENTAL

Remote Patient Monitoring system

Intervention Type DEVICE

RMS consists of an initial assessment visit and system installation: A nurse trained by the EPOCA team will conduct a comprehensive assessment of the patient's needs during a home visit within 48 hours of enrollment. This includes collecting biometric measurements, socio-economic profile, and completing a questionnaire with the patient. The initial visit also includes a consultation with a physician. All the information is transmitted to a digital platform accordingly a personalized care plan (PCP) will be defined. The nurse installs a telemonitoring kit for the patient and gives them instructions on how to use it.

The PCP manager will be responsible for implementing and overseeing the patient care plan, including informing the relevant stakeholders. Patients will be monitored via regular data feedback from the connected devices, the physician and the PCP manager. The PCP manager will treat any identified anomalies or abnormalities and implement the necessary changes on the PCP.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Remote Patient Monitoring system

RMS consists of an initial assessment visit and system installation: A nurse trained by the EPOCA team will conduct a comprehensive assessment of the patient's needs during a home visit within 48 hours of enrollment. This includes collecting biometric measurements, socio-economic profile, and completing a questionnaire with the patient. The initial visit also includes a consultation with a physician. All the information is transmitted to a digital platform accordingly a personalized care plan (PCP) will be defined. The nurse installs a telemonitoring kit for the patient and gives them instructions on how to use it.

The PCP manager will be responsible for implementing and overseeing the patient care plan, including informing the relevant stakeholders. Patients will be monitored via regular data feedback from the connected devices, the physician and the PCP manager. The PCP manager will treat any identified anomalies or abnormalities and implement the necessary changes on the PCP.

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Age ≥ 75 years,
* Three or more chronic pathologies (e.g., diabetes, heart disease, depression, cancer, respiratory failure, renal failure, dementia),
* Hospitalization or fall at least once in the previous year (Y-1),
* Recently discharged from the emergency department (within 24 hours),
* Patients, with or without caregivers, who accepted to participate and provided informed consent.

Exclusion Criteria

* Patients discharged to or having been institutionalized in nursing homes (EHPAD),
* Patients enrolled in another clinical trial
* Suicidal or hetero-aggressive risk in a patient alone at home,
* Homeless patients,
* Patients protected by the following French legal measure: "sauvegarde de justice"
Minimum Eligible Age

75 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

EPOCA U&I

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Elise CABANES, MD

Role: CONTACT

Damien TESTA, Ph.D.

Role: CONTACT

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

EPOCA-CT-2024-001

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Telemonitoring Versus Usual Care
NCT01056640 COMPLETED PHASE2/PHASE3